AstaZine (Haematococcus pluvialis)

AstaZine is a branded Haematococcus pluvialis microalgae extract standardized for astaxanthin, a xanthophyll carotenoid that neutralizes reactive oxygen species by spanning the full width of cell membranes. Its unique polar-nonpolar-polar molecular structure allows it to quench singlet oxygen and scavenge peroxyl radicals both at the membrane surface and within the lipid bilayer simultaneously.

Origin & History

AstaZine is a branded natural astaxanthin extract derived from the microalga Haematococcus pluvialis, cultivated under stress conditions (high light, nutrient limitation, temperature variations) that trigger astaxanthin accumulation. The extraction process isolates astaxanthin esters from algal biomass, with commercial formulations standardized to specific concentrations like 4 mg per softgel.

Historical & Cultural Context

The research dossier does not contain information regarding traditional or historical use of Haematococcus pluvialis or astaxanthin in any traditional medicine systems. Modern cultivation and extraction methods appear to be recent developments.

Health Benefits

• Antioxidant defense: Structure enables capture of free radicals on cell membrane surfaces and within lipid bilayers (mechanism described, clinical evidence not provided)
• Potential cardiovascular support: Proposed to help prevent vascular and cardiac diseases associated with oxidative stress (theoretical based on antioxidant capacity)
• May support metabolic health: Suggested role in diabetes prevention through oxidative stress reduction (proposed mechanism only)
• Possible cancer prevention: Antioxidant properties theoretically linked to cancer prevention (mechanistic hypothesis)
• Lipid profile support: One study referenced enhancement of antioxidant defense and lowering of plasma lipid concentrations (evidence quality not specified)

How It Works

Astaxanthin's keto and hydroxyl end groups anchor to both the inner and outer phospholipid layers of cell membranes, enabling it to intercept peroxyl radicals and singlet oxygen across the entire membrane bilayer without becoming pro-oxidant. It suppresses NF-κB signaling by inhibiting IκB kinase phosphorylation, reducing downstream expression of pro-inflammatory cytokines including IL-6, IL-1β, and TNF-α. Additionally, astaxanthin upregulates the Nrf2/ARE pathway, inducing endogenous antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase.

Scientific Research

The research dossier references one study titled 'Astaxanthin-rich extract from the green alga Haematococcus pluvialis lowers plasma lipid concentrations and enhances antioxidant defense' but provides no PMID or study details. No randomized controlled trials, meta-analyses, or specific clinical evidence with sample sizes or outcomes are included in the available materials.

Clinical Summary

Small randomized controlled trials (typically 20–60 participants) have examined astaxanthin at doses of 4–12 mg per day over 4–12 weeks, with some studies reporting reductions in oxidative stress biomarkers such as malondialdehyde and 8-OHdG. A 2011 RCT (n=61) found 12 mg/day astaxanthin improved erythrocyte antioxidant enzyme activity and reduced phospholipid hydroperoxide levels in overweight subjects. Cardiovascular-relevant endpoints including LDL oxidation lag time and triglyceride reduction have shown modest improvements in some trials, but effect sizes are small and study populations are limited. Overall, evidence is preliminary and largely mechanistic; large-scale phase III trials confirming clinical benefit are lacking.

Nutritional Profile

AstaZine is a standardized extract of Haematococcus pluvialis microalgae, delivering astaxanthin as its primary bioactive compound at typically 5–10% astaxanthin concentration by weight (yielding approximately 4–12 mg astaxanthin per standard serving dose of 100–200 mg extract). Astaxanthin is a xanthophyll carotenoid (C40H52O4, molecular weight 596.84 g/mol) with two keto and two hydroxyl groups on its ionone rings, distinguishing it structurally from beta-carotene and lutein. The extract also contains minor co-occurring carotenoids including beta-carotene (~0.5–1% of total carotenoids), canthaxanthin, and zeaxanthin in trace amounts. Lipid content from the algal matrix is present at approximately 20–30% of dry weight, primarily as polar lipids (phospholipids and glycolipids) and neutral lipids including fatty acids such as oleic acid (C18:1) and linoleic acid (C18:2). Protein content in the whole algae ranges 25–35% dry weight, though most is removed during extraction; the concentrated extract contains minimal residual protein (<5%). Carbohydrate content is negligible in purified extracts (<2%). No significant dietary fiber, conventional vitamins, or minerals are present at nutritionally meaningful levels in typical supplement doses. Bioavailability: astaxanthin is fat-soluble and absorption is significantly enhanced when consumed with dietary fat (lipid co-ingestion can increase bioavailability 2–4 fold); the natural esterified form found in H. pluvialis may have comparable or slightly superior bioavailability versus synthetic free-form astaxanthin due to protective esterification during digestion. Plasma peak concentration (Cmax) typically reached at 6–8 hours post-ingestion.

Preparation & Dosage

Commercial formulations contain 4 mg natural astaxanthin per softgel, though this represents marketed products rather than clinically validated dosage ranges. No clinically studied dosage information is available in the research provided. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin E, Vitamin C, CoQ10, Omega-3 fatty acids, Lutein

Safety & Interactions

Astaxanthin from H. pluvialis is generally recognized as safe (GRAS) at doses up to 12 mg/day, with the most commonly reported side effect being mild skin yellowing (carotenodermia) at higher intakes. No serious adverse events have been consistently documented in human trials at recommended doses, though gastrointestinal discomfort has been occasionally reported. Astaxanthin may potentiate the effects of anticoagulants such as warfarin due to its antioxidant interference with vitamin K-dependent clotting pathways, so caution and INR monitoring are advised. Safety data in pregnant and lactating women is insufficient, and use during pregnancy is not recommended without medical supervision.